Trial intelligence / Profile preview

Intravenous Vitamin C in Septic Patients

NCT04137276Completed

Sponsor
Universitas Indonesia
Start
Apr 2019
Primary completion
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of ascorbic acid in sepsis (2 arms), sponsored by Universitas Indonesia. Primary endpoint: Sequential Organ Failure Assessment at 72 hours. Started Apr 2019; status: completed.

02

Drugs

ascorbic acid
03

Conditions

sepsis

Beyond the preview

Go deeper on NCT04137276.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04137276.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call